查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1800150

全球手術密封劑市場：2025 年至 2030 年預測

Global Surgical Sealants Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 156 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計手術密封劑市場將從 2025 年的 20.19 億美元成長到 2030 年的 32.02 億美元，複合年成長率為 9.66%。

手術密封劑市場正經歷顯著成長，這得益於微創手術需求的不斷成長，微創手術可縮短患者的康復時間、縮短住院時間並降低相關費用。生物來源、合成和半合成的手術密封劑正日益取代傳統的縫合線和縫合釘，因為它們能夠閉合手術傷口，並有效控制術中和術後出血。與疼痛且有感染風險的縫線不同，密封劑提供了一種創傷更小、更有效率的替代方案，可改善患者的治療效果。

該領域的一項顯著進展是MeTro外科黏合劑的開發，這是一種利用彈性蛋白的高彈性密封劑。這項創新技術由雪梨大學的生物醫學工程師及其美國合作夥伴共同研發，塗抹後即可凝膠化，可長時間保留在傷口上，並促進傷口在60秒內快速癒合。 MeTro專為高難度外科手術的閉合而設計，例如涉及肺部、心臟和動脈的手術，這些手術再次手術具有很高的風險。該技術將由Elastagen Pty Ltd.進行商業化，代表著外科護理發展的關鍵一步。

市場區隔分析

按形式

手術密封劑市場分為生物密封劑和合成密封劑兩類。生物密封劑主要以纖維蛋白為基礎，可作為促進創傷治療的模板，但其來源為動物或人體，因此具有較高的疾病傳播風險。另一方面，合成密封劑可活化凝血連鎖，控制術中出血，由於其安全性和有效性，預計將佔據相當大的市場佔有率。

按地區

北美市場佔據主導地位，因為該地區較早採用先進技術，且大量人口尋求外科治療。該地區的收入最高，百特國際、CryoLife、CR Bard、CSL Behring、Cohera Medical 和強生等主要企業引領著產業發展。同時，亞太地區可望實現顯著成長，預測期內複合年成長率顯著。這一成長的驅動力包括醫療基礎設施的改善、老年人口的成長，以及中國和印度等國家道路交通事故導致的外科手術增多。這些因素極大地推動了該地區對外科密封劑的需求。

摘要，受MeTro黏合劑等技術創新以及人們對微創手術日益成長的偏好推動，手術密封劑市場正在快速發展。北美持續維持收益領先地位，而亞太地區則因人口和基礎設施發展而展現出強勁的成長潛力。

本報告的主要優點

  • 深入分析：深入了解主要和新興地區的市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解主要企業採用的策略策略，並了解正確策略的市場滲透潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力來提供策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，都是有益且具有成本效益的。

它有什麼用途？

產業與市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2020 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測細分市場和區域分析（包括國家）
  • 公司概況（尤其是趨勢）、財務資訊和關鍵發展

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

5. 全球外科密封劑市場（按類型）

  • 介紹
  • 合成
  • 生物

6. 全球外科密封劑市場（按類型）

  • 介紹
  • 纖維蛋白膠
  • 膠原蛋白基密封劑
  • 氰基丙烯酸酯
  • 白蛋白和戊二醛基密封劑
  • 聚乙二醇（PEG）水凝膠
  • 其他

7. 全球手術密封劑市場（按應用）

  • 介紹
  • 心血管外科
  • 神經外科
  • 整形外科
  • 一般外科
  • 肺部手術
  • 整容手術
  • 其他

8. 全球外科密封劑市場（依最終用戶）

  • 介紹
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

9. 全球外科密封劑市場（按地區）

  • 介紹
  • 北美洲
    • 按形式
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按形式
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 按形式
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 按形式
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 按形式
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第11章 公司簡介

  • Johnson & Johnson
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • CSL Behring
  • Artivion Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic plc
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Arch Therapeutics, Inc.

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611189

The Global Surgical Sealants Market is expected to grow from USD 2.019 billion in 2025 to USD 3.202 billion in 2030, at a CAGR of 9.66%.

The global surgical sealants market is experiencing significant growth, driven by the increasing demand for minimally invasive surgeries, which reduce patient recovery time, hospital stays, and associated costs. Surgical sealants, encompassing biologically derived, synthetic, and semi-synthetic forms, are replacing traditional sutures and staples due to their ability to close surgical wounds and control active bleeding effectively during and post-surgery. Unlike sutures, which can be painful and carry infection risks, sealants offer a less invasive and more efficient alternative, enhancing patient outcomes.

A notable advancement in this field is the development of MeTro surgical glue, a highly elastic sealant utilizing elastin protein. This innovative technology, developed by biomedical engineers from the University of Sydney and collaborators in the United States, transforms into a gel upon application, enabling prolonged retention on wounds and promoting rapid healing within 60 seconds. MeTro is particularly designed for challenging surgical closures, such as those involving the lungs, heart, and arteries, where reopening poses significant risks. The technology is set to be commercialized by Elastagen Pty Ltd., marking a pivotal step in advancing surgical care.

Market Segmentation Analysis

By Form

The surgical sealants market is segmented into biological and synthetic categories. Biological sealants, primarily fibrin-based, act as a template for accelerated wound healing but carry a higher risk of disease transmission due to their animal or human-derived origins. In contrast, synthetic sealants, which activate blood clotting cascades to control intraoperative bleeding, are gaining traction and are expected to capture a significant market share due to their safety profile and efficacy.

By Geography

North America dominates the market, driven by the early adoption of advanced technologies and a substantial population seeking surgical care. The region generates the highest revenue, with key players such as Baxter International, CryoLife, C.R. Bard, CSL Behring, Cohera Medical, and Johnson & Johnson leading the industry. Meanwhile, the Asia Pacific region is poised for substantial growth, with a notable compound annual growth rate (CAGR) during the forecast period. This growth is fueled by improving healthcare infrastructure, a rising geriatric population, and an increase in surgical procedures due to road accidents in countries like China and India. These factors are significantly boosting the demand for surgical sealants in the region.

In summary, the surgical sealants market is advancing rapidly, propelled by technological innovations like MeTro glue and the growing preference for minimally invasive procedures. North America remains the revenue leader, while the Asia Pacific region shows strong growth potential due to demographic and infrastructural developments.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Surgical Sealants Market Segmentation:

By Form

  • Synthetic
  • Biological

By Type

  • Fibrin Sealants
  • Collagen-based Sealants
  • Cyanoacrylates
  • Albumin and Glutaraldehyde-based Sealants
  • Polyethylene Glycol (PEG) Hydrogels
  • Others

By Application

  • Cardiovascular surgery
  • Neurological surgery
  • Orthopedic surgery
  • General surgery
  • Pulmonary surgery
  • Cosmetic surgery
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia Pacific

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SURGICAL SEALANTS MARKET BY FORM

  • 5.1. Introduction
  • 5.2. Synthetic
  • 5.3. Biological

6. GLOBAL SURGICAL SEALANTS MARKET BY TYPE

  • 6.1. Introduction
  • 6.2. Fibrin Sealants
  • 6.3. Collagen-based Sealants
  • 6.4. Cyanoacrylates
  • 6.5. Albumin and Glutaraldehyde-based Sealants
  • 6.6. Polyethylene Glycol (PEG) Hydrogels
  • 6.7. Others

7. GLOBAL SURGICAL SEALANTS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Cardiovascular surgery
  • 7.3. Neurological surgery
  • 7.4. Orthopedic surgery
  • 7.5. General surgery
  • 7.6. Pulmonary surgery
  • 7.7. Cosmetic surgery
  • 7.8. Others

8. GLOBAL SURGICAL SEALANTS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. GLOBAL SURGICAL SEALANTS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Form
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Form
    • 9.3.2. By Type
    • 9.3.3. By Application
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Form
    • 9.4.2. By Type
    • 9.4.3. By Application
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Form
    • 9.5.2. By Type
    • 9.5.3. By Application
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Form
    • 9.6.2. By Type
    • 9.6.3. By Application
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Johnson & Johnson
  • 11.2. Baxter International Inc.
  • 11.3. Becton, Dickinson and Company
  • 11.4. CSL Behring
  • 11.5. Artivion Inc.
  • 11.6. Integra LifeSciences Holdings Corporation
  • 11.7. Medtronic plc
  • 11.8. Zimmer Biomet
  • 11.9. B. Braun Melsungen AG
  • 11.10. Arch Therapeutics, Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations